{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:08:13Z","timestamp":1788448093702,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2320-B-039-026-"],"award-info":[{"award-number":["108-2320-B-039-026-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-341-002-"],"award-info":[{"award-number":["109-2320-B-341-002-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-109-238"],"award-info":[{"award-number":["DMR-109-238"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Medical University under the Higher Education Sprout Project, Ministry of Education, Taiwan"},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["2020SKHBND001"],"award-info":[{"award-number":["2020SKHBND001"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2021,2,25]]},"DOI":"10.1038\/s41388-020-01613-4","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T17:03:01Z","timestamp":1610730181000},"page":"1503-1515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases"],"prefix":"10.1038","volume":"40","author":[{"given":"Po-I","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Lin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Huang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hao","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-8716","authenticated-orcid":false,"given":"Wei-Chien","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-7927","authenticated-orcid":false,"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-8352","authenticated-orcid":false,"given":"Chih-Hsin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"1613_CR1","first-page":"24","volume":"32","author":"H Chin","year":"2015","unstructured":"Chin H, Kim J. Bone Metastasis: Concise Overview. Fed Pract: Health Care Prof VA, DoD, PHS. 2015;32:24\u201330.","journal-title":"Fed Pract: Health Care Prof VA, DoD, PHS"},{"key":"1613_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.11622\/smedj.2014138","volume":"55","author":"VA Singh","year":"2014","unstructured":"Singh VA, Haseeb A, Alkubaisi AA. Incidence and outcome of bone metastatic disease at University Malaya Medical Centre. Singap Med J. 2014;55:539\u201346.","journal-title":"Singap Med J"},{"key":"1613_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016022","volume":"7","author":"E Svensson","year":"2017","unstructured":"Svensson E, Christiansen CF, Ulrichsen SP, Rorth MR, Sorensen HT. Survival after bone metastasis by primary cancer type: a Danish population-based cohort study. BMJ Open. 2017;7:e016022.","journal-title":"BMJ Open"},{"key":"1613_CR4","first-page":"321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, et al. Bone metastases: an overview. Oncol Rev. 2017;11:321.","journal-title":"Oncol Rev"},{"key":"1613_CR5","doi-asserted-by":"publisher","first-page":"148.","DOI":"10.3390\/ijms19010148","volume":"19","author":"A Schmid-Alliana","year":"2018","unstructured":"Schmid-Alliana A, Schmid-Antomarchi H, Al-Sahlanee R, Lagadec P, Scimeca JC, Verron E. Understanding the progression of bone metastases to identify novel therapeutic targets. Int J Mol Sci. 2018;19:148.","journal-title":"Int J Mol Sci"},{"key":"1613_CR6","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","volume":"6","author":"LA Kingsley","year":"2007","unstructured":"Kingsley LA, Fournier PG, Chirgwin JM, Guise TA. Molecular biology of bone metastasis. Mol Cancer Ther. 2007;6:2609\u201317.","journal-title":"Mol Cancer Ther"},{"key":"1613_CR7","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1210\/jc.2018-02236","volume":"104","author":"H Lyu","year":"2019","unstructured":"Lyu H, Jundi B, Xu C, Tedeschi SK, Yoshida K, Zhao S, et al. Comparison of Denosumab and Bisphosphonates in patients with osteoporosis: a meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2019;104:1753\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"1613_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1758834011412656","volume":"3","author":"GG Steger","year":"2011","unstructured":"Steger GG, Bartsch R. Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion. Ther Adv Med Oncol. 2011;3:233\u201343.","journal-title":"Ther Adv Med Oncol"},{"key":"1613_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.afos.2016.03.003","volume":"2","author":"B Benjamin","year":"2016","unstructured":"Benjamin B, Benjamin MA, Swe M, Sugathan S. Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis. Osteoporos Sarcopenia. 2016;2:77\u201381.","journal-title":"Osteoporos Sarcopenia"},{"key":"1613_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00508-006-0644-8","volume":"118","author":"A Wutzl","year":"2006","unstructured":"Wutzl A, Eisenmenger G, Hoffmann M, Czerny C, Moser D, Pietschmann P, et al. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients. Wien Klinische Wochenschr. 2006;118:473\u20138.","journal-title":"Wien Klinische Wochenschr"},{"key":"1613_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiodt M. Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev. 2018;69:177\u201387.","journal-title":"Cancer Treat Rev"},{"key":"1613_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.20945\/2359-3997000000066","volume":"62","author":"FGD Amaral","year":"2018","unstructured":"Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab. 2018;62:472\u20139.","journal-title":"Arch Endocrinol Metab"},{"key":"1613_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jid.2017.10.025","volume":"138","author":"AT Slominski","year":"2018","unstructured":"Slominski AT, Hardeland R, Zmijewski MA, Slominski RM, Reiter RJ, Paus R. Melatonin: a cutaneous perspective on its production, metabolism, and functions. J Invest Dermatol. 2018;138:490\u20139.","journal-title":"J Invest Dermatol"},{"key":"1613_CR14","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/jcp.27090","volume":"234","author":"B Wang","year":"2019","unstructured":"Wang B, Wen H, Smith W, Hao D, He B, Kong L. Regulation effects of melatonin on bone marrow mesenchymal stem cell differentiation. J Cell Physiol. 2019;234:1008\u201315.","journal-title":"J Cell Physiol"},{"key":"1613_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.stem.2018.08.002","volume":"23","author":"K Golan","year":"2018","unstructured":"Golan K, Kumari A, Kollet O, Khatib-Massalha E, Subramaniam MD, Ferreira ZS, et al. Daily onset of light and darkness differentially controls hematopoietic stem cell differentiation and maintenance. Cell Stem Cell. 2018;23:572\u201385 e577.","journal-title":"Cell Stem Cell"},{"key":"1613_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2019.08.008","volume":"78","author":"K Golan","year":"2019","unstructured":"Golan K, Kollet O, Markus RP, Lapidot T. Daily light and darkness onset and circadian rhythms metabolically synchronize hematopoietic stem cell differentiation and maintenance: the role of bone marrow norepinephrine, tumor necrosis factor, and melatonin cycles. Exp Hematol. 2019;78:1\u201310.","journal-title":"Exp Hematol"},{"key":"1613_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61652-5","volume":"10","author":"MO Cordoba-Moreno","year":"2020","unstructured":"Cordoba-Moreno MO, de Souza EDS, Quiles CL, Dos Santos-Silva D, Kinker GS, Muxel SM, et al. Rhythmic expression of the melatonergic biosynthetic pathway and its differential modulation in vitro by LPS and IL10 in bone marrow and spleen. Sci Rep. 2020;10:4799.","journal-title":"Sci Rep"},{"key":"1613_CR18","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1111\/bph.14083","volume":"175","author":"RP Markus","year":"2018","unstructured":"Markus RP, Fernandes PA, Kinker GS, da Silveira Cruz-Machado S, Marcola M. Immune-pineal axis \u2013 acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. Br J Pharm. 2018;175:3239\u201350.","journal-title":"Br J Pharm"},{"key":"1613_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","volume":"15","author":"S Tordjman","year":"2017","unstructured":"Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, et al. Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 2017;15:434\u201343.","journal-title":"Curr Neuropharmacol"},{"key":"1613_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/07420520500464361","volume":"23","author":"J Arendt","year":"2006","unstructured":"Arendt J. Melatonin and human rhythms. Chronobiol Int. 2006;23:21\u201337.","journal-title":"Chronobiol Int"},{"key":"1613_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.msard.2014.12.001","volume":"4","author":"G Anderson","year":"2015","unstructured":"Anderson G, Rodriguez M. Multiple sclerosis: the role of melatonin and N-acetylserotonin. Mult Scler Relat Disord. 2015;4:112\u201323.","journal-title":"Mult Scler Relat Disord"},{"key":"1613_CR22","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1111\/bph.13898","volume":"175","author":"R Jahanban-Esfahlan","year":"2018","unstructured":"Jahanban-Esfahlan R, Mehrzadi S, Reiter RJ, Seidi K, Majidinia M, Baghi HB, et al. Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes. Br J Pharm. 2018;175:3230\u20138.","journal-title":"Br J Pharm"},{"key":"1613_CR23","doi-asserted-by":"publisher","first-page":"39896","DOI":"10.18632\/oncotarget.16379","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, et al. Melatonin for the prevention and treatment of cancer. Oncotarget. 2017;8:39896\u2013921.","journal-title":"Oncotarget"},{"key":"1613_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12557","volume":"66","author":"JW Lv","year":"2019","unstructured":"Lv JW, Zheng ZQ, Wang ZX, Zhou GQ, Chen L, Mao YP, et al. Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types. J Pineal Res. 2019;66:e12557.","journal-title":"J Pineal Res"},{"key":"1613_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","volume":"56","author":"J Liu","year":"2016","unstructured":"Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol. 2016;56:361\u201383.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1613_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fncel.2017.00199","volume":"11","author":"B Leaw","year":"2017","unstructured":"Leaw B, Nair S, Lim R, Thornton C, Mallard C, Hagberg H. Mitochondria, bioenergetics and excitotoxicity: new therapeutic targets in perinatal brain injury. Front Cell Neurosci. 2017;11:199.","journal-title":"Front Cell Neurosci"},{"key":"1613_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NSS.S181365","volume":"11","author":"A Boafo","year":"2019","unstructured":"Boafo A, Greenham S, Alenezi S, Robillard R, Pajer K, Tavakoli P, et al. Could long-term administration of melatonin to prepubertal children affect timing of puberty? A clinician\u2019s perspective. Nat Sci Sleep. 2019;11:1\u201310.","journal-title":"Nat Sci Sleep"},{"key":"1613_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","volume":"473","author":"K Matsuo","year":"2008","unstructured":"Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys. 2008;473:201\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"1613_CR29","doi-asserted-by":"publisher","first-page":"22041","DOI":"10.1074\/jbc.274.31.22041","volume":"274","author":"JA Roth","year":"1999","unstructured":"Roth JA, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem. 1999;274:22041\u20137.","journal-title":"J Biol Chem"},{"key":"1613_CR30","doi-asserted-by":"publisher","first-page":"1142.","DOI":"10.3390\/ijms18061142","volume":"18","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Kim HJ, Bae MK, Kim YD. Suppression of osteoclastogenesis by melatonin: a melatonin receptor-independent action. Int J Mol Sci. 2017;18:1142.","journal-title":"Int J Mol Sci"},{"key":"1613_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1359\/jbmr.2002.17.7.1219","volume":"17","author":"H Koyama","year":"2002","unstructured":"Koyama H, Nakade O, Takada Y, Kaku T, Lau KH. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res: Off J Am Soc Bone Miner Res. 2002;17:1219\u201329.","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"1613_CR32","doi-asserted-by":"publisher","first-page":"2452.","DOI":"10.3390\/ijms20102452","volume":"20","author":"M Lopez-Canul","year":"2019","unstructured":"Lopez-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, et al. Melatonin MT1 and MT2 receptors exhibit distinct effects in the modulation of body temperature across the light\/dark cycle. Int J Mol Sci. 2019;20:2452.","journal-title":"Int J Mol Sci"},{"key":"1613_CR33","doi-asserted-by":"publisher","first-page":"694.","DOI":"10.3390\/genes11060694","volume":"11","author":"LR Watkins","year":"2020","unstructured":"Watkins LR, Orlandi C, Orphan G. Protein coupled receptors in affective disorders. Genes. 2020;11:694.","journal-title":"Genes"},{"key":"1613_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1042\/CS20180945","volume":"133","author":"CC Chao","year":"2019","unstructured":"Chao CC, Chen PC, Chiou PC, Hsu CJ, Liu PI, Yang YC, et al. Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist. Clin Sci. 2019;133:709\u201322.","journal-title":"Clin Sci"},{"key":"1613_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fmed.2017.00234","volume":"4","author":"H Bi","year":"2017","unstructured":"Bi H, Chen X, Gao S, Yu X, Xiao J, Zhang B, et al. Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review. Front Med. 2017;4:234.","journal-title":"Front Med"},{"key":"1613_CR36","doi-asserted-by":"publisher","first-page":"182.","DOI":"10.3390\/cancers10060182","volume":"10","author":"AB Shupp","year":"2018","unstructured":"Shupp AB, Kolb AD, Mukhopadhyay D, Bussard KM. Cancer metastases to bone: concepts, mechanisms, and interactions with bone osteoblasts. Cancers. 2018;10:182.","journal-title":"Cancers"},{"key":"1613_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4068\/cmj.2016.52.1.12","volume":"52","author":"JH Kim","year":"2016","unstructured":"Kim JH, Kim N. Signaling pathways in osteoclast differentiation. Chonnam Med J. 2016;52:12\u20137.","journal-title":"Chonnam Med J"},{"key":"1613_CR38","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/01.blo.0000093055.96273.69","volume":"(415 Suppl)","author":"TA Guise","year":"2003","unstructured":"Guise TA, Chirgwin JM. Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop Relat Res. 2003;(415 Suppl):S32\u20138.","journal-title":"Clin Orthop Relat Res"},{"key":"1613_CR39","first-page":"683","volume":"128","author":"TW Fowler","year":"2015","unstructured":"Fowler TW, Kamalakar A, Akel NS, Kurten RC, Suva LJ, Gaddy D. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. J Cell Sci. 2015;128:683\u201394.","journal-title":"J Cell Sci"},{"key":"1613_CR40","doi-asserted-by":"publisher","first-page":"2183.","DOI":"10.3390\/ijms20092183","volume":"20","author":"PA van Dam","year":"2019","unstructured":"van Dam PA, Verhoeven Y, Jacobs J, Wouters A, Tjalma W, Lardon F, et al. RANK-RANKL signaling in cancer of the uterine cervix: a review. Int J Mol Sci. 2019;20:2183.","journal-title":"Int J Mol Sci"},{"key":"1613_CR41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","volume":"275","author":"T Nakashima","year":"2000","unstructured":"Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000;275:768\u201375.","journal-title":"Biochem Biophys Res Commun"},{"key":"1613_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1447-0756.2008.00818.x","volume":"34","author":"M Watanabe","year":"2008","unstructured":"Watanabe M, Kobayashi Y, Takahashi N, Kiguchi K, Ishizuka B. Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line. J Obstet Gynaecol Res. 2008;34:567\u201373.","journal-title":"J Obstet Gynaecol Res"},{"key":"1613_CR43","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3892\/ol.2014.1813","volume":"7","author":"A Cutando","year":"2014","unstructured":"Cutando A, Lopez-Valverde A, Dev J, Gimenez JL, Carcia IA, Ded RG. Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review). Oncol Lett. 2014;7:923\u20136.","journal-title":"Oncol Lett"},{"key":"1613_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","volume":"23","author":"SR Pandi-Perumal","year":"2013","unstructured":"Pandi-Perumal SR, BaHammam AS, Brown GM, Spence DW, Bharti VK, Kaur C, et al. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. Neurotox Res. 2013;23:267\u2013300.","journal-title":"Neurotox Res"},{"key":"1613_CR45","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res: Off J Am Assoc Cancer Res. 2006;12:6243s\u20139s.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"1613_CR46","doi-asserted-by":"publisher","unstructured":"Maria S, Samsonraj RM, Munmun F, Glas J, Silvestros M, Kotlarczyk MP, et al. Biological effects of melatonin on osteoblast\/osteoclast cocultures, bone, and quality of life: implications of a role for MT2 melatonin receptors, MEK1\/2, and MEK5 in melatonin-mediated osteoblastogenesis. J Pineal Res. 2018;64: https:\/\/doi.org\/10.1111\/jpi.12465.","DOI":"10.1111\/jpi.12465"},{"key":"1613_CR47","doi-asserted-by":"publisher","first-page":"18002.","DOI":"10.1038\/nrdp.2018.2","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Prim. 2018;4:18002.","journal-title":"Nat Rev Dis Prim"},{"key":"1613_CR48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00296-010-1641-9","volume":"32","author":"J Bang","year":"2012","unstructured":"Bang J, Chang HW, Jung HR, Cho CH, Hur JA, Lee SI, et al. Melatonin attenuates clock gene cryptochrome1, which may aggravate mouse anti-type II collagen antibody-induced arthritis. Rheumatol Int. 2012;32:379\u201385.","journal-title":"Rheumatol Int"},{"key":"1613_CR49","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S1567-5769(02)00088-7","volume":"2","author":"Q Chen","year":"2002","unstructured":"Chen Q, Wei W. Effects and mechanisms of melatonin on inflammatory and immune responses of adjuvant arthritis rat. Int Immunopharmacol. 2002;2:1443\u20139.","journal-title":"Int Immunopharmacol"},{"key":"1613_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12560","volume":"66","author":"CC Huang","year":"2019","unstructured":"Huang CC, Chiou CH, Liu SC, Hu SL, Su CM, Tsai CH, et al. Melatonin attenuates TNF-alpha and IL-1beta expression in synovial fibroblasts and diminishes cartilage degradation: implications for the treatment of rheumatoid arthritis. J Pineal Res. 2019;66:e12560.","journal-title":"J Pineal Res"},{"key":"1613_CR51","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/mol.104.000398","volume":"66","author":"MA Ayoub","year":"2004","unstructured":"Ayoub MA, Levoye A, Delagrange P, Jockers R. Preferential formation of MT1\/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol. 2004;66:312\u201321.","journal-title":"Mol Pharmacol"},{"key":"1613_CR52","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.mce.2012.01.004","volume":"351","author":"RM Slominski","year":"2012","unstructured":"Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol. 2012;351:152\u201366.","journal-title":"Mol Cell Endocrinol"},{"key":"1613_CR53","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1158\/0008-5472.CAN-06-1776","volume":"66","author":"B Jung","year":"2006","unstructured":"Jung B, Ahmad N. Melatonin in cancer management: progress and promise. Cancer Res. 2006;66:9789\u201393.","journal-title":"Cancer Res"},{"key":"1613_CR54","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1007\/s00018-017-2617-7","volume":"74","author":"AT Slominski","year":"2017","unstructured":"Slominski AT, Zmijewski MA, Semak I, Kim TK, Janjetovic Z, Slominski RM, et al. Melatonin, mitochondria, and the skin. Cell Mol Life Sci. 2017;74:3913\u201325.","journal-title":"Cell Mol Life Sci"},{"key":"1613_CR55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/tox.22674","volume":"34","author":"YC Yang","year":"2019","unstructured":"Yang YC, Chiou PC, Chen PC, Liu PY, Huang WC, Chao CC, et al. Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, beta-catenin, and twist pathways. Environ Toxicol. 2019;34:203\u20139.","journal-title":"Environ Toxicol"},{"key":"1613_CR56","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1096\/fj.12-224691","volume":"27","author":"TK Kim","year":"2013","unstructured":"Kim TK, Kleszczynski K, Janjetovic Z, Sweatman T, Lin Z, Li W, et al. Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J: Off Publ Federation Am Soc Exp Biol. 2013;27:2742\u201355.","journal-title":"FASEB J: Off Publ Federation Am Soc Exp Biol"},{"key":"1613_CR57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/exd.13208","volume":"26","author":"AT Slominski","year":"2017","unstructured":"Slominski AT, Semak I, Fischer TW, Kim TK, Kleszczynski K, Hardeland R, et al. Metabolism of melatonin in the skin: why is it important? Exp Dermatol. 2017;26:563\u20138.","journal-title":"Exp Dermatol"},{"key":"1613_CR58","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.pharep.2018.05.007","volume":"70","author":"A Leja-Szpak","year":"2018","unstructured":"Leja-Szpak A, Nawrot-Porabka K, Goralska M, Jastrzebska M, Link-Lenczowski P, Bonior J, et al. Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1). Pharmacol Rep. 2018;70:1079\u201388.","journal-title":"Pharmacol Rep"},{"key":"1613_CR59","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/bjc.1995.164","volume":"71","author":"P Lissoni","year":"1995","unstructured":"Lissoni P, Barni S, Meregalli S, Fossati V, Cazzaniga M, Esposti D, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer. 1995;71:854\u20136.","journal-title":"Br J Cancer"},{"key":"1613_CR60","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/030089169408000611","volume":"80","author":"P Lissoni","year":"1994","unstructured":"Lissoni P, Meregalli S, Fossati V, Paolorossi F, Barni S, Tancini G, et al. A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer. Tumori. 1994;80:464\u20137.","journal-title":"Tumori"},{"key":"1613_CR61","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.2147\/OTT.S174100","volume":"11","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang P, Zheng X, Du X. Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis. Onco Targets Ther. 2018;11:7895\u2013908.","journal-title":"Onco Targets Ther"},{"key":"1613_CR62","doi-asserted-by":"publisher","first-page":"3271948","DOI":"10.1155\/2018\/3271948","volume":"2018","author":"J Menendez-Menendez","year":"2018","unstructured":"Menendez-Menendez J, Martinez-Campa C. Melatonin: an anti-tumor agent in hormone-dependent cancers. Int J Endocrinol. 2018;2018:3271948.","journal-title":"Int J Endocrinol"},{"key":"1613_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231379","volume":"15","author":"ACS Palmer","year":"2020","unstructured":"Palmer ACS, Zortea M, Souza A, Santos V, Biazus JV, Torres ILS, et al. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: a randomized, double-blind, placebo-controlled trial. PLoS ONE. 2020;15:e0231379.","journal-title":"PLoS ONE"},{"key":"1613_CR64","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1534735411425484","volume":"11","author":"D Seely","year":"2012","unstructured":"Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ, et al. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther. 2012;11:293\u2013303.","journal-title":"Integr Cancer Ther"},{"key":"1613_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fonc.2017.00163","volume":"7","author":"MC Farach-Carson","year":"2017","unstructured":"Farach-Carson MC, Lin SH, Nalty T, Satcher RL. Sex differences and bone metastases of breast, lung, and prostate cancers: do bone homing cancers favor feminized bone marrow? Front Oncol. 2017;7:163.","journal-title":"Front Oncol"},{"key":"1613_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jnci\/dji002","volume":"97","author":"JE Brown","year":"2005","unstructured":"Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, et al. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97:59\u201369.","journal-title":"J Natl Cancer Inst"},{"key":"1613_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia. 2005;10:169\u201380.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"1613_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jbo.2018.07.011","volume":"12","author":"V Rouach","year":"2018","unstructured":"Rouach V, Goldshtein I, Wolf I, Catane R, Chodick G, Iton A, et al. Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer. J Bone Oncol. 2018;12:91\u20135.","journal-title":"J Bone Oncol"},{"key":"1613_CR69","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1158\/0008-5472.CAN-13-3156","volume":"74","author":"RT Dauchy","year":"2014","unstructured":"Dauchy RT, Xiang S, Mao L, Brimer S, Wren MA, Yuan L, et al. Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res. 2014;74:4099\u2013110.","journal-title":"Cancer Res"},{"key":"1613_CR70","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","volume":"65","author":"CL Hall","year":"2005","unstructured":"Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res. 2005;65:7554\u201360.","journal-title":"Cancer Res"},{"key":"1613_CR71","doi-asserted-by":"publisher","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","volume":"12","author":"TA Guise","year":"2006","unstructured":"Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, et al. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res: Off J Am Assoc Cancer Res. 2006;12:6213s\u20136s.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"1613_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06304-x","volume":"7","author":"Y Han","year":"2017","unstructured":"Han Y, Kim YM, Kim HS, Lee KY. Melatonin promotes osteoblast differentiation by regulating Osterix protein stability and expression. Sci Rep. 2017;7:5716.","journal-title":"Sci Rep"},{"key":"1613_CR73","first-page":"7202","volume":"17","author":"X Meng","year":"2018","unstructured":"Meng X, Zhu Y, Tao L, Zhao S, Qiu S. miR-590-3p mediates melatonin-induced cell apoptosis by targeting septin 7 in the human osteoblast cell line hFOB 1.19. Mol Med Rep. 2018;17:7202\u20138.","journal-title":"Mol Med Rep"},{"key":"1613_CR74","doi-asserted-by":"publisher","first-page":"1491.","DOI":"10.3390\/ijms17091491","volume":"17","author":"JF Liu","year":"2016","unstructured":"Liu JF, Chen CY, Chen HT, Chang CS, Tang CH. BL-038, a Benzofuran derivative, induces cell apoptosis in human chondrosarcoma cells through reactive oxygen species\/mitochondrial dysfunction and the caspases dependent pathway. Int J Mol Sci. 2016;17:1491.","journal-title":"Int J Mol Sci"},{"key":"1613_CR75","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/09540105.2019.1660623","volume":"30","author":"HP Lee","year":"2019","unstructured":"Lee HP, Wang SW, Wu YC, Tsai CH, Tsai FJ, Chung JG, et al. Glucocerebroside reduces endothelial progenitor cell-induced angiogenesis. Food Agr Immunol. 2019;30:1033\u201345.","journal-title":"Food Agr Immunol"},{"key":"1613_CR76","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jff.2018.11.040","volume":"52","author":"HP Lee","year":"2019","unstructured":"Lee HP, Chen PC, Wang SW, Fong YC, Tsai CH, Tsai FJ, et al. Plumbagin suppresses endothelial progenitor cell-related angiogenesis in vitro and in vivo. J Funct Foods. 2019;52:537\u201344.","journal-title":"J Funct Foods"},{"key":"1613_CR77","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/09540105.2020.1713055","volume":"31","author":"HP Lee","year":"2020","unstructured":"Lee HP, Wang SW, Wu YC, Lin LW, Tsai FJ, Yang JS, et al. Soya-cerebroside inhibits VEGF-facilitated angiogenesis in endothelial progenitor cells. Food Agr Immunol. 2020;31:193\u2013204.","journal-title":"Food Agr Immunol"},{"key":"1613_CR78","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1002\/jcp.23043","volume":"227","author":"MH Wu","year":"2012","unstructured":"Wu MH, Lo JF, Kuo CH, Lin JA, Lin YM, Chen LM, et al. Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK\/PI3K\/Akt\/mTOR pathways. J Cell Physiol. 2012;227:3016\u201326.","journal-title":"J Cell Physiol"},{"key":"1613_CR79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bcp.2019.05.005","volume":"166","author":"M Wang","year":"2019","unstructured":"Wang M, Chao CC, Chen PC, Liu PI, Yang YC, Su CM, et al. Thrombospondin enhances RANKL-dependent osteoclastogenesis and facilitates lung cancer bone metastasis. Biochem Pharmacol. 2019;166:23\u201332.","journal-title":"Biochem Pharmacol"},{"key":"1613_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078022","volume":"8","author":"JY Chuang","year":"2013","unstructured":"Chuang JY, Chang AC, Chiang IP, Tsai MH, Tang CH. Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells. PloS ONE. 2013;8:e78022.","journal-title":"PloS ONE"},{"key":"1613_CR81","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/carcin\/bgt103","volume":"34","author":"PC Chen","year":"2013","unstructured":"Chen PC, Cheng HC, Tang CH. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway. Carcinogenesis. 2013;34:1669\u201379.","journal-title":"Carcinogenesis"},{"key":"1613_CR82","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2018.03.050","volume":"426","author":"AC Chang","year":"2018","unstructured":"Chang AC, Chen PC, Lin YF, Su CM, Liu JF, Lin TH, et al. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1\/integrin alpha4beta1 system. Cancer Lett. 2018;426:47\u201356.","journal-title":"Cancer Lett"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01613-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01613-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01613-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T04:56:04Z","timestamp":1674881764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01613-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,2,25]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-01613-4","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}